GoodRx (NASDAQ:GDRX) versus Health Catalyst (NASDAQ:HCAT) Financial Contrast

Health Catalyst (NASDAQ:HCAT – Get Free Report) and GoodRx (NASDAQ:GDRX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Profitability

This table compares Health Catalyst and GoodRx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Health Catalyst -90.61% -1.83% -0.80%
GoodRx 2.07% 7.22% 2.53%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Health Catalyst and GoodRx, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst 1 7 3 0 2.18
GoodRx 3 6 4 0 2.08

Health Catalyst presently has a consensus price target of $2.45, suggesting a potential upside of 40.00%. GoodRx has a consensus price target of $4.23, suggesting a potential upside of 28.88%. Given Health Catalyst’s stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than GoodRx.

Volatility and Risk

Health Catalyst has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500.

Institutional & Insider Ownership

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Health Catalyst and GoodRx”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Health Catalyst $311.14 million 0.42 -$177.97 million ($3.68) -0.48
GoodRx $796.85 million 1.41 $30.44 million $0.04 82.00

GoodRx has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Summary

GoodRx beats Health Catalyst on 10 of the 14 factors compared between the two stocks.

About Health Catalyst

(Get Free Report)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

About GoodRx

(Get Free Report)

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.